Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 4/2021

20.09.2021 | Case Report

Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?

verfasst von: Babette Van Rafelghem, Adrian Covaci, Kurt Anseeuw, Alexander L. N. van Nuijs, Hugo Neels, Boris Mahieu, Werner Jacobs

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

A 22-year-old man was hospitalized after stating he would ‘commit suicide in a non-detectable way’. He was admitted with a severe necrotizing pancreatitis and acute kidney injury, evolving to multiple organ failure. His condition rapidly deteriorated, and he died 11 days after hospital admission. Postmortem histopathology confirmed fulminant necrotizing pancreatitis, acute tubular necrosis, cerebral edema, pericentral/midzonal hepatocellular necrosis and acute respiratory distress syndrome. Metabolites of 4F-MDMB-BINACA, a synthetic cannabinoid, were detected in urine and serum collected at hospital admission. The same drug was found in a vapor fluid found in the man’s apartment. As cannabis use has been etiologically linked to acute pancreatitis, we hypothesize that the more afferent and potent 4F-MDMB-BINACA could induce acute pancreatitis via stimulation of cannabinoid (CB)1-receptors. Alternatively, terminal fluorination could have induced a dose-dependent toxic effect on a wide range of cellular processes, leading to cell dysfunction and death. This is the first clinicopathological description of a lethal intoxication with 4F-MDMB-BINACA, following extensive vaping. Toxic effects could either relate to CB-receptor binding or to direct fluoride toxicity.
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):96–8. Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):96–8.
2.
Zurück zum Zitat Krotulski AJ, Mohr ALA, Kacinko SL, et al. 4F-MDMB-BINACA: A new synthetic cannabinoid widely implicated in forensic casework. J Forensic Sci. 2019;64:1451–61.CrossRef Krotulski AJ, Mohr ALA, Kacinko SL, et al. 4F-MDMB-BINACA: A new synthetic cannabinoid widely implicated in forensic casework. J Forensic Sci. 2019;64:1451–61.CrossRef
3.
Zurück zum Zitat Banister SD, Stuart J, Kevin RC, et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6:1445–58.CrossRef Banister SD, Stuart J, Kevin RC, et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6:1445–58.CrossRef
4.
Zurück zum Zitat World Health Organization. Critical Review Report: 4F-MDMB-BINACA. WHO expert committe drug depend. 2019. World Health Organization. Critical Review Report: 4F-MDMB-BINACA. WHO expert committe drug depend. 2019.
5.
Zurück zum Zitat Haschimi B, Mogler L, Halter S, et al. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in “legal high” products and human urine specimens. Drug Test Anal. 2019;11:1377–86.CrossRef Haschimi B, Mogler L, Halter S, et al. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in “legal high” products and human urine specimens. Drug Test Anal. 2019;11:1377–86.CrossRef
6.
Zurück zum Zitat Belze O, Legras A, Ehrmann S, et al. Cannabis-induced acute pancreatitis. Am J Emerg Med. 2011;29(131):e3-4. Belze O, Legras A, Ehrmann S, et al. Cannabis-induced acute pancreatitis. Am J Emerg Med. 2011;29(131):e3-4.
7.
Zurück zum Zitat Juan-Picó P, Fuentes E, Javier Bermúdez-Silva F, et al. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell. Cell Calcium. 2006;39:155–62.CrossRef Juan-Picó P, Fuentes E, Javier Bermúdez-Silva F, et al. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell. Cell Calcium. 2006;39:155–62.CrossRef
8.
Zurück zum Zitat Linari G, Agostini S, Amadoro G, et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res. 2009;59:207–14.CrossRef Linari G, Agostini S, Amadoro G, et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res. 2009;59:207–14.CrossRef
9.
Zurück zum Zitat Wargo KA, Geveden BN, McConnell VJ. Cannabinoid-induced pancreatitis: A case series. J Pancreas. 2007;8:579–83. Wargo KA, Geveden BN, McConnell VJ. Cannabinoid-induced pancreatitis: A case series. J Pancreas. 2007;8:579–83.
10.
Zurück zum Zitat Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: Clinical and laboratory findings. Addiction. 2013;108:534–44.CrossRef Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: Clinical and laboratory findings. Addiction. 2013;108:534–44.CrossRef
11.
Zurück zum Zitat Centers for Disease Control and Prevention. Notes from the field: Hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase—Denver, Colorado, 2012. JAMA. 2013;6:108. Centers for Disease Control and Prevention. Notes from the field: Hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase—Denver, Colorado, 2012. JAMA. 2013;6:108.
12.
Zurück zum Zitat Silva JP, Carmo H, Carvalho F. The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis. Toxicol Lett. 2018;287:59–69.CrossRef Silva JP, Carmo H, Carvalho F. The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis. Toxicol Lett. 2018;287:59–69.CrossRef
13.
Zurück zum Zitat Buser GL, Gerona RR, Horowitz BZ, et al. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol. 2014;52:664–73.CrossRef Buser GL, Gerona RR, Horowitz BZ, et al. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol. 2014;52:664–73.CrossRef
14.
Zurück zum Zitat Araujo TT, Barbosa Silva Pereira HA, Dionizio A, et al. Changes in energy metabolism induced by fluoride: Insights from inside the mitochondria. Chemosphere. 2019;236:124357.CrossRef Araujo TT, Barbosa Silva Pereira HA, Dionizio A, et al. Changes in energy metabolism induced by fluoride: Insights from inside the mitochondria. Chemosphere. 2019;236:124357.CrossRef
15.
Zurück zum Zitat Usuda K, Kono K, Dote T, et al. Usefulness of the assessment of urinary enzyme leakage in monitoring acute fluoride nephrotoxicity. Arch Toxicol. 1999;73:346–51.CrossRef Usuda K, Kono K, Dote T, et al. Usefulness of the assessment of urinary enzyme leakage in monitoring acute fluoride nephrotoxicity. Arch Toxicol. 1999;73:346–51.CrossRef
16.
Zurück zum Zitat Barbier O, Arreola-Mendoza L, Del Razo LM. Molecular mechanisms of fluoride toxicity. Chem Biol Interact. 2010;188:319–33.CrossRef Barbier O, Arreola-Mendoza L, Del Razo LM. Molecular mechanisms of fluoride toxicity. Chem Biol Interact. 2010;188:319–33.CrossRef
17.
Zurück zum Zitat Song C, Fu B, Zhang J, et al. Sodium fluoride induces nephrotoxicity via oxidative stress-regulated mitochondrial SIRT3 signaling pathway. Sci Rep. 2017;7:672.CrossRef Song C, Fu B, Zhang J, et al. Sodium fluoride induces nephrotoxicity via oxidative stress-regulated mitochondrial SIRT3 signaling pathway. Sci Rep. 2017;7:672.CrossRef
18.
Zurück zum Zitat Larsson A, Ristoff E, Anderson ME. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995. Larsson A, Ristoff E, Anderson ME. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995.
Metadaten
Titel
Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?
verfasst von
Babette Van Rafelghem
Adrian Covaci
Kurt Anseeuw
Alexander L. N. van Nuijs
Hugo Neels
Boris Mahieu
Werner Jacobs
Publikationsdatum
20.09.2021
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 4/2021
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-021-00424-7

Weitere Artikel der Ausgabe 4/2021

Forensic Science, Medicine and Pathology 4/2021 Zur Ausgabe

Letter to the Editor

Clandestine mummified remains

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …